PuSH - Publikationsserver des Helmholtz Zentrums München: Genetische Prädisposition und Umweltfaktoren in der Pathogenese des Typ-1-Diabetes.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Hummel, S. ; Ziegler, A.-G.

Genetische Prädisposition und Umweltfaktoren in der Pathogenese des Typ-1-Diabetes.

Genetic predisposition and environmental factors in the pathogenesis of type 1 diabetes.

Internist. Prax. 66, 373-383 (2023)

Verlagsversion

Zum Artikel

	Closed

Abstract
Metriken
Zusatzinfos

Type 1 diabetes (T1D) is one of the most common chronic diseases in childhood caused by autoimmune-mediated destruction of the insulin-producing pancreatic islet ß-cells. Prospective birth cohort studies contributed to the identification of genetic and environmental factors involved in the pathogenesis of type 1 diabetes. The development and validation of a genetic risk score enabled risk prediction for later development of type 1 diabetes. Consistent findings from prospective studies point to the contribution of intrauterine maternal type 1 diabetes exposure, early childhood viral infections, early childhood growth/obesity, and gut microbiome/dysbiosis in the pathogenesis of type 1 diabetes. Launched in late 2017, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) was designed to carry out newborn screening in the general population, identify infants at high genetic risk of developing type 1 diabetes, and offer them participation in trials to prevent disease initiation.

Impact Factor

Scopus SNIP

0.000

0.001